Merck to boost next decade revenue forecast on new drugs optimism

By Michael Erman and Kamal Choudhury NEW YORK, Oct 29 (Reuters) – Merck said on Thursday it plans to raise its revenue forecast from new products over the next decade, buoyed by recent clinical trial

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)